nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—Non-Nucleoside Reverse Transcriptase Inhibitors—Delavirdine—acquired immunodeficiency syndrome	0.124	0.19	CiPCiCtD
Nevirapine—Non-Nucleoside Analog—Delavirdine—acquired immunodeficiency syndrome	0.124	0.19	CiPCiCtD
Nevirapine—Cytochrome P450 3A Inducers—Ritonavir—acquired immunodeficiency syndrome	0.0898	0.138	CiPCiCtD
Nevirapine—Cytochrome P450 3A Inducers—Efavirenz—acquired immunodeficiency syndrome	0.0898	0.138	CiPCiCtD
Nevirapine—Non-Nucleoside Analog—Efavirenz—acquired immunodeficiency syndrome	0.0751	0.115	CiPCiCtD
Nevirapine—Cytochrome P450 2B6 Inducers—Efavirenz—acquired immunodeficiency syndrome	0.0751	0.115	CiPCiCtD
Nevirapine—Non-Nucleoside Reverse Transcriptase Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.0751	0.115	CiPCiCtD
Nevirapine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0125	0.0501	CbGbCtD
Nevirapine—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0118	0.0476	CbGbCtD
Nevirapine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0117	0.0471	CbGbCtD
Nevirapine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0106	0.0426	CbGbCtD
Nevirapine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00888	0.0357	CbGbCtD
Nevirapine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00835	0.0336	CbGbCtD
Nevirapine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00835	0.0336	CbGbCtD
Nevirapine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00803	0.0323	CbGbCtD
Nevirapine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00731	0.0294	CbGbCtD
Nevirapine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00721	0.029	CbGbCtD
Nevirapine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.007	0.0281	CbGbCtD
Nevirapine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.00687	0.0276	CbGbCtD
Nevirapine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00659	0.0265	CbGbCtD
Nevirapine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00633	0.0255	CbGbCtD
Nevirapine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00633	0.0255	CbGbCtD
Nevirapine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00621	0.025	CbGbCtD
Nevirapine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00619	0.0249	CbGbCtD
Nevirapine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00602	0.0242	CbGbCtD
Nevirapine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00566	0.0228	CbGbCtD
Nevirapine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0056	0.0225	CbGbCtD
Nevirapine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0056	0.0225	CbGbCtD
Nevirapine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00521	0.0209	CbGbCtD
Nevirapine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00512	0.0206	CbGbCtD
Nevirapine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00512	0.0206	CbGbCtD
Nevirapine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00483	0.0194	CbGbCtD
Nevirapine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00471	0.0189	CbGbCtD
Nevirapine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00469	0.0189	CbGbCtD
Nevirapine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00442	0.0178	CbGbCtD
Nevirapine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00429	0.0173	CbGbCtD
Nevirapine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00424	0.0171	CbGbCtD
Nevirapine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00424	0.0171	CbGbCtD
Nevirapine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00407	0.0164	CbGbCtD
Nevirapine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00388	0.0156	CbGbCtD
Nevirapine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00388	0.0156	CbGbCtD
Nevirapine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00383	0.0154	CbGbCtD
Nevirapine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0036	0.0145	CbGbCtD
Nevirapine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00326	0.0131	CbGbCtD
Nevirapine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00326	0.0131	CbGbCtD
Nevirapine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00281	0.0113	CbGbCtD
Nevirapine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00273	0.011	CbGbCtD
Nevirapine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00247	0.00993	CbGbCtD
Nevirapine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00247	0.00993	CbGbCtD
Nevirapine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00237	0.00952	CbGbCtD
Nevirapine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000224	0.0658	CbGeAlD
Nevirapine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000216	0.0635	CbGeAlD
Nevirapine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000214	0.0631	CbGeAlD
Nevirapine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000212	0.0625	CbGeAlD
Nevirapine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000162	0.0477	CbGeAlD
Nevirapine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000159	0.0469	CbGeAlD
Nevirapine—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000145	0.0426	CbGeAlD
Nevirapine—CYP2A6—lung—acquired immunodeficiency syndrome	0.000137	0.0402	CbGeAlD
Nevirapine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000103	0.0303	CbGeAlD
Nevirapine—CYP2A6—brain—acquired immunodeficiency syndrome	9.68e-05	0.0285	CbGeAlD
Nevirapine—CYP1A2—digestive system—acquired immunodeficiency syndrome	8.6e-05	0.0253	CbGeAlD
Nevirapine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	8.35e-05	0.0246	CbGeAlD
Nevirapine—CYP3A5—digestive system—acquired immunodeficiency syndrome	8.3e-05	0.0244	CbGeAlD
Nevirapine—CYP2B6—digestive system—acquired immunodeficiency syndrome	8.25e-05	0.0243	CbGeAlD
Nevirapine—CYP1A2—blood—acquired immunodeficiency syndrome	8.2e-05	0.0241	CbGeAlD
Nevirapine—CYP2C9—digestive system—acquired immunodeficiency syndrome	8.17e-05	0.024	CbGeAlD
Nevirapine—CYP3A5—blood—acquired immunodeficiency syndrome	7.91e-05	0.0233	CbGeAlD
Nevirapine—CYP2B6—blood—acquired immunodeficiency syndrome	7.86e-05	0.0231	CbGeAlD
Nevirapine—CYP2C9—blood—acquired immunodeficiency syndrome	7.78e-05	0.0229	CbGeAlD
Nevirapine—CYP3A5—vagina—acquired immunodeficiency syndrome	7.33e-05	0.0216	CbGeAlD
Nevirapine—CYP2B6—vagina—acquired immunodeficiency syndrome	7.28e-05	0.0214	CbGeAlD
Nevirapine—CYP1A2—lung—acquired immunodeficiency syndrome	7.19e-05	0.0211	CbGeAlD
Nevirapine—CYP3A5—lung—acquired immunodeficiency syndrome	6.93e-05	0.0204	CbGeAlD
Nevirapine—CYP2B6—lung—acquired immunodeficiency syndrome	6.89e-05	0.0203	CbGeAlD
Nevirapine—CYP2B6—nervous system—acquired immunodeficiency syndrome	6.38e-05	0.0188	CbGeAlD
Nevirapine—CYP3A4—digestive system—acquired immunodeficiency syndrome	6.23e-05	0.0183	CbGeAlD
Nevirapine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	6.14e-05	0.0181	CbGeAlD
Nevirapine—CYP2D6—digestive system—acquired immunodeficiency syndrome	6.13e-05	0.018	CbGeAlD
Nevirapine—CYP3A4—blood—acquired immunodeficiency syndrome	5.93e-05	0.0175	CbGeAlD
Nevirapine—CYP2D6—blood—acquired immunodeficiency syndrome	5.84e-05	0.0172	CbGeAlD
Nevirapine—CYP2B6—brain—acquired immunodeficiency syndrome	4.88e-05	0.0143	CbGeAlD
Nevirapine—CYP3A4—nervous system—acquired immunodeficiency syndrome	4.82e-05	0.0142	CbGeAlD
Nevirapine—CYP2D6—nervous system—acquired immunodeficiency syndrome	4.74e-05	0.0139	CbGeAlD
Nevirapine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	4.64e-05	0.0136	CbGeAlD
Nevirapine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	4.56e-05	0.0134	CbGeAlD
Nevirapine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	3.89e-05	0.00041	CcSEcCtD
Nevirapine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	3.89e-05	0.00041	CcSEcCtD
Nevirapine—Rash—Amprenavir—acquired immunodeficiency syndrome	3.89e-05	0.00041	CcSEcCtD
Nevirapine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	3.89e-05	0.00041	CcSEcCtD
Nevirapine—Urticaria—Stavudine—acquired immunodeficiency syndrome	3.88e-05	0.000409	CcSEcCtD
Nevirapine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	3.87e-05	0.000408	CcSEcCtD
Nevirapine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	3.87e-05	0.000408	CcSEcCtD
Nevirapine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	3.87e-05	0.000408	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	3.87e-05	0.000408	CcSEcCtD
Nevirapine—Headache—Amprenavir—acquired immunodeficiency syndrome	3.87e-05	0.000408	CcSEcCtD
Nevirapine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	3.87e-05	0.000408	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	3.86e-05	0.000408	CcSEcCtD
Nevirapine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	3.86e-05	0.000407	CcSEcCtD
Nevirapine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	3.86e-05	0.000407	CcSEcCtD
Nevirapine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	3.85e-05	0.000406	CcSEcCtD
Nevirapine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	3.85e-05	0.000406	CcSEcCtD
Nevirapine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	3.84e-05	0.000405	CcSEcCtD
Nevirapine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	3.83e-05	0.000404	CcSEcCtD
Nevirapine—Urticaria—Abacavir—acquired immunodeficiency syndrome	3.82e-05	0.000403	CcSEcCtD
Nevirapine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	3.81e-05	0.000402	CcSEcCtD
Nevirapine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	3.8e-05	0.000401	CcSEcCtD
Nevirapine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	3.8e-05	0.000401	CcSEcCtD
Nevirapine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	3.77e-05	0.000398	CcSEcCtD
Nevirapine—Anorexia—Indinavir—acquired immunodeficiency syndrome	3.76e-05	0.000397	CcSEcCtD
Nevirapine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	3.75e-05	0.000396	CcSEcCtD
Nevirapine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	3.74e-05	0.000394	CcSEcCtD
Nevirapine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	3.72e-05	0.000393	CcSEcCtD
Nevirapine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	3.72e-05	0.000393	CcSEcCtD
Nevirapine—Erythema—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000392	CcSEcCtD
Nevirapine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	3.69e-05	0.000389	CcSEcCtD
Nevirapine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	3.68e-05	0.000388	CcSEcCtD
Nevirapine—Nausea—Amprenavir—acquired immunodeficiency syndrome	3.67e-05	0.000387	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	3.66e-05	0.000387	CcSEcCtD
Nevirapine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	3.66e-05	0.000386	CcSEcCtD
Nevirapine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	3.66e-05	0.000386	CcSEcCtD
Nevirapine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	3.65e-05	0.000385	CcSEcCtD
Nevirapine—Malaise—Ritonavir—acquired immunodeficiency syndrome	3.65e-05	0.000385	CcSEcCtD
Nevirapine—Pain—Zidovudine—acquired immunodeficiency syndrome	3.63e-05	0.000383	CcSEcCtD
Nevirapine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	3.62e-05	0.000382	CcSEcCtD
Nevirapine—CYP2D6—brain—acquired immunodeficiency syndrome	3.62e-05	0.0107	CbGeAlD
Nevirapine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	3.61e-05	0.000381	CcSEcCtD
Nevirapine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	3.61e-05	0.000381	CcSEcCtD
Nevirapine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	3.6e-05	0.00038	CcSEcCtD
Nevirapine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	3.6e-05	0.000379	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	3.6e-05	0.000379	CcSEcCtD
Nevirapine—Vomiting—Didanosine—acquired immunodeficiency syndrome	3.58e-05	0.000377	CcSEcCtD
Nevirapine—Oedema—Delavirdine—acquired immunodeficiency syndrome	3.57e-05	0.000376	CcSEcCtD
Nevirapine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	3.56e-05	0.000375	CcSEcCtD
Nevirapine—Rash—Didanosine—acquired immunodeficiency syndrome	3.55e-05	0.000374	CcSEcCtD
Nevirapine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	3.55e-05	0.000374	CcSEcCtD
Nevirapine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	3.54e-05	0.000374	CcSEcCtD
Nevirapine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	3.54e-05	0.000374	CcSEcCtD
Nevirapine—Headache—Didanosine—acquired immunodeficiency syndrome	3.52e-05	0.000372	CcSEcCtD
Nevirapine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	3.52e-05	0.000371	CcSEcCtD
Nevirapine—Malaise—Saquinavir—acquired immunodeficiency syndrome	3.51e-05	0.00037	CcSEcCtD
Nevirapine—Somnolence—Indinavir—acquired immunodeficiency syndrome	3.51e-05	0.00037	CcSEcCtD
Nevirapine—Asthenia—Stavudine—acquired immunodeficiency syndrome	3.5e-05	0.00037	CcSEcCtD
Nevirapine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	3.5e-05	0.000369	CcSEcCtD
Nevirapine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	3.49e-05	0.000369	CcSEcCtD
Nevirapine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	3.47e-05	0.000366	CcSEcCtD
Nevirapine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	3.47e-05	0.000366	CcSEcCtD
Nevirapine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	3.47e-05	0.000366	CcSEcCtD
Nevirapine—Pruritus—Stavudine—acquired immunodeficiency syndrome	3.46e-05	0.000364	CcSEcCtD
Nevirapine—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.45e-05	0.000364	CcSEcCtD
Nevirapine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000363	CcSEcCtD
Nevirapine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	3.44e-05	0.000363	CcSEcCtD
Nevirapine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.44e-05	0.000363	CcSEcCtD
Nevirapine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.43e-05	0.000362	CcSEcCtD
Nevirapine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.43e-05	0.000362	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.42e-05	0.000361	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.41e-05	0.000359	CcSEcCtD
Nevirapine—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.4e-05	0.000359	CcSEcCtD
Nevirapine—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.4e-05	0.000359	CcSEcCtD
Nevirapine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.4e-05	0.000359	CcSEcCtD
Nevirapine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.4e-05	0.000359	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.4e-05	0.000358	CcSEcCtD
Nevirapine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	3.39e-05	0.000358	CcSEcCtD
Nevirapine—Pain—Indinavir—acquired immunodeficiency syndrome	3.38e-05	0.000356	CcSEcCtD
Nevirapine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.37e-05	0.000356	CcSEcCtD
Nevirapine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.36e-05	0.000354	CcSEcCtD
Nevirapine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.36e-05	0.000354	CcSEcCtD
Nevirapine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.35e-05	0.000354	CcSEcCtD
Nevirapine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.35e-05	0.000353	CcSEcCtD
Nevirapine—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.35e-05	0.000353	CcSEcCtD
Nevirapine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.34e-05	0.000352	CcSEcCtD
Nevirapine—Nausea—Didanosine—acquired immunodeficiency syndrome	3.34e-05	0.000352	CcSEcCtD
Nevirapine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.32e-05	0.00035	CcSEcCtD
Nevirapine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.31e-05	0.00035	CcSEcCtD
Nevirapine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.31e-05	0.00035	CcSEcCtD
Nevirapine—Oedema—Ritonavir—acquired immunodeficiency syndrome	3.3e-05	0.000348	CcSEcCtD
Nevirapine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.29e-05	0.000347	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.29e-05	0.000347	CcSEcCtD
Nevirapine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000345	CcSEcCtD
Nevirapine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.25e-05	0.000343	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.25e-05	0.000343	CcSEcCtD
Nevirapine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.24e-05	0.000342	CcSEcCtD
Nevirapine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.24e-05	0.000341	CcSEcCtD
Nevirapine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.23e-05	0.000341	CcSEcCtD
Nevirapine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.23e-05	0.00034	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.22e-05	0.00034	CcSEcCtD
Nevirapine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.22e-05	0.000339	CcSEcCtD
Nevirapine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.21e-05	0.000338	CcSEcCtD
Nevirapine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.2e-05	0.000338	CcSEcCtD
Nevirapine—Pain—Efavirenz—acquired immunodeficiency syndrome	3.19e-05	0.000336	CcSEcCtD
Nevirapine—Oedema—Saquinavir—acquired immunodeficiency syndrome	3.18e-05	0.000335	CcSEcCtD
Nevirapine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.17e-05	0.000335	CcSEcCtD
Nevirapine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.16e-05	0.000333	CcSEcCtD
Nevirapine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.16e-05	0.000333	CcSEcCtD
Nevirapine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.15e-05	0.000332	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.14e-05	0.000331	CcSEcCtD
Nevirapine—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.14e-05	0.000331	CcSEcCtD
Nevirapine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.12e-05	0.000329	CcSEcCtD
Nevirapine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.12e-05	0.000329	CcSEcCtD
Nevirapine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.12e-05	0.000329	CcSEcCtD
Nevirapine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.12e-05	0.000329	CcSEcCtD
Nevirapine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.11e-05	0.000329	CcSEcCtD
Nevirapine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.11e-05	0.000328	CcSEcCtD
Nevirapine—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.11e-05	0.000328	CcSEcCtD
Nevirapine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.1e-05	0.000327	CcSEcCtD
Nevirapine—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.09e-05	0.000326	CcSEcCtD
Nevirapine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.09e-05	0.000325	CcSEcCtD
Nevirapine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.09e-05	0.000325	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.08e-05	0.000325	CcSEcCtD
Nevirapine—Rash—Stavudine—acquired immunodeficiency syndrome	3.08e-05	0.000325	CcSEcCtD
Nevirapine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.08e-05	0.000325	CcSEcCtD
Nevirapine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.08e-05	0.000325	CcSEcCtD
Nevirapine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.07e-05	0.000324	CcSEcCtD
Nevirapine—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.07e-05	0.000324	CcSEcCtD
Nevirapine—Headache—Stavudine—acquired immunodeficiency syndrome	3.06e-05	0.000323	CcSEcCtD
Nevirapine—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.06e-05	0.000323	CcSEcCtD
Nevirapine—Pain—Delavirdine—acquired immunodeficiency syndrome	3.05e-05	0.000322	CcSEcCtD
Nevirapine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.05e-05	0.000322	CcSEcCtD
Nevirapine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.05e-05	0.000321	CcSEcCtD
Nevirapine—Rash—Abacavir—acquired immunodeficiency syndrome	3.03e-05	0.00032	CcSEcCtD
Nevirapine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.03e-05	0.00032	CcSEcCtD
Nevirapine—Oedema—Lamivudine—acquired immunodeficiency syndrome	3.03e-05	0.00032	CcSEcCtD
Nevirapine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.03e-05	0.00032	CcSEcCtD
Nevirapine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.03e-05	0.000319	CcSEcCtD
Nevirapine—Headache—Abacavir—acquired immunodeficiency syndrome	3.01e-05	0.000318	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.01e-05	0.000317	CcSEcCtD
Nevirapine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3e-05	0.000317	CcSEcCtD
Nevirapine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	2.97e-05	0.000313	CcSEcCtD
Nevirapine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2.97e-05	0.000313	CcSEcCtD
Nevirapine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.96e-05	0.000313	CcSEcCtD
Nevirapine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	2.96e-05	0.000313	CcSEcCtD
Nevirapine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	2.95e-05	0.000311	CcSEcCtD
Nevirapine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.95e-05	0.000311	CcSEcCtD
Nevirapine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	2.94e-05	0.00031	CcSEcCtD
Nevirapine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	2.94e-05	0.00031	CcSEcCtD
Nevirapine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	2.93e-05	0.000309	CcSEcCtD
Nevirapine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.92e-05	0.000308	CcSEcCtD
Nevirapine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.91e-05	0.000307	CcSEcCtD
Nevirapine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.91e-05	0.000307	CcSEcCtD
Nevirapine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.9e-05	0.000306	CcSEcCtD
Nevirapine—Nausea—Stavudine—acquired immunodeficiency syndrome	2.9e-05	0.000306	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.89e-05	0.000305	CcSEcCtD
Nevirapine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.89e-05	0.000305	CcSEcCtD
Nevirapine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.87e-05	0.000303	CcSEcCtD
Nevirapine—Nausea—Abacavir—acquired immunodeficiency syndrome	2.86e-05	0.000301	CcSEcCtD
Nevirapine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	2.85e-05	0.000301	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	2.85e-05	0.000301	CcSEcCtD
Nevirapine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	2.85e-05	0.0003	CcSEcCtD
Nevirapine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	2.84e-05	0.000299	CcSEcCtD
Nevirapine—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.83e-05	0.000299	CcSEcCtD
Nevirapine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	2.82e-05	0.000298	CcSEcCtD
Nevirapine—Pain—Ritonavir—acquired immunodeficiency syndrome	2.82e-05	0.000298	CcSEcCtD
Nevirapine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	2.82e-05	0.000298	CcSEcCtD
Nevirapine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.82e-05	0.000298	CcSEcCtD
Nevirapine—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.79e-05	0.000295	CcSEcCtD
Nevirapine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.76e-05	0.000291	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.76e-05	0.000291	CcSEcCtD
Nevirapine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.75e-05	0.00029	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.000289	CcSEcCtD
Nevirapine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.000289	CcSEcCtD
Nevirapine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.72e-05	0.000287	CcSEcCtD
Nevirapine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.72e-05	0.000287	CcSEcCtD
Nevirapine—Pain—Saquinavir—acquired immunodeficiency syndrome	2.72e-05	0.000287	CcSEcCtD
Nevirapine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.7e-05	0.000285	CcSEcCtD
Nevirapine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.7e-05	0.000285	CcSEcCtD
Nevirapine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.7e-05	0.000285	CcSEcCtD
Nevirapine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.69e-05	0.000284	CcSEcCtD
Nevirapine—Rash—Zidovudine—acquired immunodeficiency syndrome	2.68e-05	0.000282	CcSEcCtD
Nevirapine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.68e-05	0.000282	CcSEcCtD
Nevirapine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.67e-05	0.000282	CcSEcCtD
Nevirapine—Headache—Zidovudine—acquired immunodeficiency syndrome	2.66e-05	0.00028	CcSEcCtD
Nevirapine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.64e-05	0.000278	CcSEcCtD
Nevirapine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.63e-05	0.000278	CcSEcCtD
Nevirapine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.63e-05	0.000277	CcSEcCtD
Nevirapine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	2.62e-05	0.000277	CcSEcCtD
Nevirapine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.62e-05	0.000276	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.62e-05	0.000276	CcSEcCtD
Nevirapine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000276	CcSEcCtD
Nevirapine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.61e-05	0.000275	CcSEcCtD
Nevirapine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.61e-05	0.000275	CcSEcCtD
Nevirapine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.6e-05	0.000274	CcSEcCtD
Nevirapine—Pain—Lamivudine—acquired immunodeficiency syndrome	2.59e-05	0.000273	CcSEcCtD
Nevirapine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.56e-05	0.00027	CcSEcCtD
Nevirapine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.55e-05	0.000269	CcSEcCtD
Nevirapine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.53e-05	0.000266	CcSEcCtD
Nevirapine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.52e-05	0.000266	CcSEcCtD
Nevirapine—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.52e-05	0.000266	CcSEcCtD
Nevirapine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.51e-05	0.000265	CcSEcCtD
Nevirapine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.51e-05	0.000265	CcSEcCtD
Nevirapine—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.51e-05	0.000265	CcSEcCtD
Nevirapine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.5e-05	0.000263	CcSEcCtD
Nevirapine—Rash—Indinavir—acquired immunodeficiency syndrome	2.49e-05	0.000263	CcSEcCtD
Nevirapine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.49e-05	0.000262	CcSEcCtD
Nevirapine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.48e-05	0.000261	CcSEcCtD
Nevirapine—Headache—Indinavir—acquired immunodeficiency syndrome	2.47e-05	0.000261	CcSEcCtD
Nevirapine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.44e-05	0.000258	CcSEcCtD
Nevirapine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.43e-05	0.000256	CcSEcCtD
Nevirapine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.41e-05	0.000254	CcSEcCtD
Nevirapine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.4e-05	0.000253	CcSEcCtD
Nevirapine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.4e-05	0.000253	CcSEcCtD
Nevirapine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.37e-05	0.00025	CcSEcCtD
Nevirapine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.37e-05	0.00025	CcSEcCtD
Nevirapine—Rash—Efavirenz—acquired immunodeficiency syndrome	2.35e-05	0.000248	CcSEcCtD
Nevirapine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.35e-05	0.000248	CcSEcCtD
Nevirapine—Nausea—Indinavir—acquired immunodeficiency syndrome	2.35e-05	0.000247	CcSEcCtD
Nevirapine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.34e-05	0.000247	CcSEcCtD
Nevirapine—Headache—Efavirenz—acquired immunodeficiency syndrome	2.34e-05	0.000246	CcSEcCtD
Nevirapine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.34e-05	0.000246	CcSEcCtD
Nevirapine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.28e-05	0.00024	CcSEcCtD
Nevirapine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.27e-05	0.000239	CcSEcCtD
Nevirapine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.26e-05	0.000238	CcSEcCtD
Nevirapine—Rash—Delavirdine—acquired immunodeficiency syndrome	2.25e-05	0.000237	CcSEcCtD
Nevirapine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.25e-05	0.000237	CcSEcCtD
Nevirapine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.25e-05	0.000237	CcSEcCtD
Nevirapine—Headache—Delavirdine—acquired immunodeficiency syndrome	2.24e-05	0.000236	CcSEcCtD
Nevirapine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.23e-05	0.000235	CcSEcCtD
Nevirapine—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.22e-05	0.000234	CcSEcCtD
Nevirapine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.17e-05	0.000229	CcSEcCtD
Nevirapine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.17e-05	0.000229	CcSEcCtD
Nevirapine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.14e-05	0.000226	CcSEcCtD
Nevirapine—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.12e-05	0.000224	CcSEcCtD
Nevirapine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.1e-05	0.000221	CcSEcCtD
Nevirapine—Rash—Ritonavir—acquired immunodeficiency syndrome	2.08e-05	0.000219	CcSEcCtD
Nevirapine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.08e-05	0.000219	CcSEcCtD
Nevirapine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.07e-05	0.000219	CcSEcCtD
Nevirapine—Headache—Ritonavir—acquired immunodeficiency syndrome	2.07e-05	0.000218	CcSEcCtD
Nevirapine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.02e-05	0.000213	CcSEcCtD
Nevirapine—Rash—Saquinavir—acquired immunodeficiency syndrome	2e-05	0.000211	CcSEcCtD
Nevirapine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2e-05	0.000211	CcSEcCtD
Nevirapine—Headache—Saquinavir—acquired immunodeficiency syndrome	1.99e-05	0.00021	CcSEcCtD
Nevirapine—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.96e-05	0.000207	CcSEcCtD
Nevirapine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.93e-05	0.000203	CcSEcCtD
Nevirapine—Rash—Lamivudine—acquired immunodeficiency syndrome	1.91e-05	0.000202	CcSEcCtD
Nevirapine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.91e-05	0.000201	CcSEcCtD
Nevirapine—Headache—Lamivudine—acquired immunodeficiency syndrome	1.9e-05	0.0002	CcSEcCtD
Nevirapine—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.89e-05	0.000199	CcSEcCtD
Nevirapine—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.8e-05	0.00019	CcSEcCtD
